ARTICLE | Clinical News

Sparlon modafinil regulatory update

April 24, 2006 7:00 AM UTC

CEPH disclosed in a SEC filing that it submitted new information to FDA last week to support its position that the skin rash on a child in a Phase III trial of ADHD treatment was not Steven Johnson's ...